Finding 559885 (2024-005)

Significant Deficiency
Requirement
N
Questioned Costs
-
Year
2024
Accepted
2025-05-08
Audit: 355815
Organization: Firstfollowers (IL)

AI Summary

  • Core Issue: There is a significant deficiency in internal controls over compliance related to the management's review and approval of expenses for federal grants.
  • Impacted Requirements: The organization failed to maintain effective internal controls as required by CFR §200.303(a), leading to inadequate documentation for 24 out of 35 disbursements.
  • Recommended Follow-Up: Enhance internal controls to ensure proper documentation of management reviews for expenses before payment to prevent incorrect charges to federal grants.

Finding Text

Federal agency: U.S. Treasury Federal program title: Coronavirus State and Local Fiscal Recovery Funds Assistance Listing Number: 21.027 Pass-Through Agency: City of Champaign, Illinois Pass-Through Number(s): 20220245; 20220246 Award Period: 3/1/2023-12/30/2023; 12/15/2023-12/31/2024; 3/1/2022-12/31/2023; 12/15/2023-12/31/2024 Type of Finding: Significant Deficiency in Internal Control over Compliance Criteria or Specific Requirement: Code of Federal Regulations (CFR) §200.303(a) indicates nonfederal entities must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the nonfederal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework,” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Condition: Lack of supporting documentation showing management's review and approval of costs as being expensed in the proper grant period. Questioned costs: N/A Context: For 24 of the 35 disbursements tested there was no documentation showing management's review and approval of the expense as being in the proper grant period. Cause: Error by management when reviewing the expenses to document their review on the invoice or other supporting documentation. Effect: If costs are not reviewed and approved, it could result in incorrect costs being charged to federal grants. Repeat Finding: N/A Recommendation: We recommend the Organization enhance its internal controls in order to require the maintaining of appropriate supporting documentation to show invoices were reviewed before paid. Views of responsible officials: The Organization will review our procedures surrounding ensuring that the proper accounting period is recorded for each transaction to identify any failures in the process.

Categories

Significant Deficiency Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 559878 2024-002
    Material Weakness Repeat
  • 559879 2024-003
    Material Weakness Repeat
  • 559880 2024-004
    Significant Deficiency Repeat
  • 559881 2024-005
    Significant Deficiency
  • 559882 2024-002
    Material Weakness Repeat
  • 559883 2024-003
    Material Weakness Repeat
  • 559884 2024-004
    Significant Deficiency Repeat
  • 559886 2024-002
    Material Weakness Repeat
  • 559887 2024-003
    Material Weakness Repeat
  • 559888 2024-004
    Significant Deficiency Repeat
  • 559889 2024-005
    Significant Deficiency
  • 559890 2024-002
    Material Weakness Repeat
  • 559891 2024-003
    Material Weakness Repeat
  • 559892 2024-004
    Significant Deficiency Repeat
  • 559893 2024-005
    Significant Deficiency
  • 1136320 2024-002
    Material Weakness Repeat
  • 1136321 2024-003
    Material Weakness Repeat
  • 1136322 2024-004
    Significant Deficiency Repeat
  • 1136323 2024-005
    Significant Deficiency
  • 1136324 2024-002
    Material Weakness Repeat
  • 1136325 2024-003
    Material Weakness Repeat
  • 1136326 2024-004
    Significant Deficiency Repeat
  • 1136327 2024-005
    Significant Deficiency
  • 1136328 2024-002
    Material Weakness Repeat
  • 1136329 2024-003
    Material Weakness Repeat
  • 1136330 2024-004
    Significant Deficiency Repeat
  • 1136331 2024-005
    Significant Deficiency
  • 1136332 2024-002
    Material Weakness Repeat
  • 1136333 2024-003
    Material Weakness Repeat
  • 1136334 2024-004
    Significant Deficiency Repeat
  • 1136335 2024-005
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
14.239 Home Investment Partnerships Program $55,600
21.027 Coronavirus State and Local Fiscal Recovery Funds $54,900